|
|
Post by hellodolly on Mar 10, 2019 13:26:54 GMT -5
From the second post above, dated Feb 25, 2019: "Majority of attendees are not from the USA and therefore not their primary target audience." Next post, quoting March 7, 2019 job advert: Wanted: Global Safety Officer with "deep knowledge and understanding of the global regulatory environment."  Sounds like an excellent response from a SWOT analysis and what it can do for your organization's long term strategic planning. You have a need (internal (W) weakness - expand the primary audience, 'globally'), utilize an (external (O) opportunity- hire a 'Global' Safety Officer) and work to make it into an organizational (S) strength. Strategic planning at it's damned finest!! You can question what's going on inside the C-Suite, but when you do...you get these answers. |
|
|
|
Post by mytakeonit on Mar 10, 2019 19:30:01 GMT -5
Calling it troubling could be fair but that's pure speculation and possibly misleading...just as it would be pure speculation and possibly misleading to believe that there could be positive things going on behind the scenes that are not being disclosed that led to the decision. Since we don't know, there's no reason to value one speculation over the other. Guessing is certainly fair. I guess that ... we'll hear about it on the conference call. |
|
|
|
Post by cretin11 on Mar 11, 2019 11:39:18 GMT -5
From the second post above, dated Feb 25, 2019: "Majority of attendees are not from the USA and therefore not their primary target audience." Next post, quoting March 7, 2019 job advert: Wanted: Global Safety Officer with "deep knowledge and understanding of the global regulatory environment." Sounds like an excellent response from a SWOT analysis and what it can do for your organization's long term strategic planning. You have a need (internal (W) weakness - expand the primary audience, 'globally'), utilize an (external (O) opportunity- hire a 'Global' Safety Officer) and work to make it into an organizational (S) strength. Strategic planning at it's damned finest!! You can question what's going on inside the C-Suite, but when you do...you get these answers. Hiring a GSO seems like a good idea, agreed. However these "answers" still don't address barnstormers questions from his post on previous page. |
|
|
|
Post by ltta on Mar 11, 2019 14:21:41 GMT -5
From the second post above, dated Feb 25, 2019: "Majority of attendees are not from the USA and therefore not their primary target audience." Next post, quoting March 7, 2019 job advert: Wanted: Global Safety Officer with "deep knowledge and understanding of the global regulatory environment." There are two troubling things. Mike told me when ADA was in San Diego they weren't going because the majority of attendees are not from the US. I can tell you that a large number of the attendees were there from the US including endos, nurse practioners and others that can help move Afrezza forward. Otherwise why did we have to wait for the STAT last year until ADA? The collaborators knew there was a strong US attendance to deliver the study too in a live setting. Secondly the hires they are making clearly reflect that were are not nearing a partnership with a big pharma company that already has regulatory and global regulatory talent in. Why duplicate? Mike did say they would look into other ways to participate in ADA. I guess we will see photos of some presense there. I would suggest that many of the global regulators will have delegates at ADA, so why not impress them ahead of a filing for approval for Afrezza? Troubling.
From the ADA website "World's Largest Diabetes Meeting"
|
|
|
|
Post by akemp3000 on Mar 11, 2019 14:31:04 GMT -5
Maybe, just maybe, Mike created a flippant excuse for pulling the booth because he felt it necessary to not disclose the real reason. Whether that reason is good or bad remains to be seen. IMO, he knows what he's doing.
|
|
|
|
Post by awesomo on Mar 11, 2019 14:46:55 GMT -5
Can we agree that the excuse was not a good one, regardless of what the actual reason was?
|
|
|
|
Post by sportsrancho on Mar 11, 2019 14:52:48 GMT -5
Can we agree that the excuse was not a good one, regardless of what the actual reason was? The catch in all this is that he used the same excuse before ..he said he was out, then he was in. I don’t think he can decide:-) |
|
|
|
Post by ltta on Mar 13, 2019 15:12:07 GMT -5
Post Date 3/11/2019 Title Patient Experience GuideCity Westlake Village State CA
Description MannKind Corporation (NASDAQ:MNKD) focuses on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. MannKind is currently commercializing Afrezza® (insulin human) inhalation powder, the Company's first FDA-approved product and the only inhaled rapid-acting mealtime insulin in the United States, where it is available by prescription from pharmacies nationwide. MannKind is headquartered in Westlake Village, California, and has a state-of-the art manufacturing facility in Danbury, Connecticut. The Company also employs field sales and medical representatives across the U.S. For further information, visit www.mannkindcorp.com. Position Summary: MannKind is currently commercializing Afrezza® (insulin human) Inhalation Powder, the Company’s first FDA approved product, in the United States, where it is available by prescription from pharmacies nationwide. Our employees are our number one asset, and we continue to be a tight-knit community where each of us has a critical role in our success. Committed to diversity, at MannKind we depend on a rich blend of ideas, backgrounds, and working styles in our quest to change the world for the better. We are currently recruiting for a Patient Experience Guide within our patient support hub at our Westlake Village, CA office. This role will give you the ability to work directly with patients and their care providers. If this is your passion, we are looking for individuals who meet the requirements below. Purpose People living with diabetes face unique challenges managing their condition. Patients need comprehensive support from their overall care team and a single point of contact that can assist with their Afrezza® journey.
The Patient Experience Guide will act as a single point of contact to support the patient from the time their health care provider writes a prescription for Afrezza® through successful, ongoing use.
Please note that this role is focused solely on providing comprehensive customer service to patients and does not involve the provision of medical advice to patients or any work, service or support on behalf of any healthcare provider(s). Key Responsibilities/Accountabilities: The Patient Experience Guide will be the single point of contact for the patient, prescriber, and other health care professionals (as appropriate). In delivering this service, the Patient Experience Guide will coordinate both externally and internally to ensure the best possible outcome for the patient. This ongoing coordination will require frequent communication and coordination with all parties, including but not limited to; the patient, provider, insurers, pharmacy benefit managers, pharmacists, clinical educators, and others.
The Patient Experience Guide will facilitate the Afrezza® journey with the patient from point of enrollment in the patient support hub service through successful use of Afrezza®.
The Patient Experience Guide will be responsible for recognizing any potential medical questions/issues and referring the patient to their healthcare professional and/or filing product complaints and adverse event reports in response. This job does not involve the practice of nursing/medicine or the provision of any medical advice to patients. Responsibilities include: Assisting patients in understanding their treatment journey, identifying and addressing barriers to access and reimbursement, addressing patient education needs, providing resources.
Focus on creating the best patient experience possible – strong patient / customer service orientation.
Maintain current subject matter expertise of diabetes marketplace dynamics and geographical / region trends- being seen as local patient market expert both externally and internally.
Utilize local subject matter expertise to proactively perform trending and analysis to appropriately plan for patient needs and identify barriers and/or improvements to program including supporting the strategic planning process at MannKind.
Serve as single point of contact for patients throughout the care continuum of enrollment, access, reimbursement, co-pay assistance, education, resource support, addressing any needs throughout.
Responsible for establishing and maintaining positive working relationships with patients and key stake holders in the patient support process (physicians, office staff, practice managers, nurses, educators, pharmacists, insurers, and others).
Independently use judgment and decision making in addressing patient needs across their care continuum.
Maintain a thorough and comprehensive understanding of privacy and information security laws and recognize the critical importance of respecting patient privacy and adhering to applicable laws at all times.
Comply fully with all applicable laws and regulations, as well as Company policies and procedures. MannKind takes its legal, regulatory and ethical responsibilities seriously and expects all employees to follow its comprehensive Healthcare Compliance Program. |
|
|
|
Post by ltta on Mar 21, 2019 18:48:53 GMT -5
Post Date 3/21/2019 Title Medical and Clinical Affairs Advisor City Field-based Description MannKind Corporation (NASDAQ:MNKD) focuses on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. MannKind is currently commercializing Afrezza® (insulin human) inhalation powder, the Company's first FDA-approved product and the only inhaled rapid-acting mealtime insulin in the United States, where it is available by prescription from pharmacies nationwide. MannKind is headquartered in Westlake Village, California, and has a state-of-the art manufacturing facility in Danbury, Connecticut. The Company also employs field sales and medical representatives across the U.S. For further information, visit www.mannkindcorp.com. The Medical and Clinical Affairs Advisor (MCAA) is a field-based extension of the Medial Affairs (MA) and Clinical Development (CD) teams responsible for serving as a scientific expert and study liaison to opinion leaders (OLs) and healthcare providers (HCPs) in the academic, medical society, and payer communities as related to MannKind products and related disease states. The MCAA will also have significant responsibility for MA and CD corporate functions as listed below (e.g. PRC, IITs, sales training, etc.). Individuals in this role will be expected to provide in-depth, scientific, clinical and educational information and support to OLs, HCPs, medical societies, and payers, as well as interact with internal clinical, sales and marketing teams to lead relevant scientific corporate activities. The MCAA will have an in-depth understanding of MannKind products and disease states relevant to business needs and will be responsible for providing scientific insights from the field to MA and CD management. In addition, the MCAA will have well-established relationships with national OLs in the diabetes therapeutic area and/or be well-equipped to develop new relationships. Individuals in these positions will provide scientific expertise in a fair balanced, objective, manner in compliance with all applicable policies, regulations, and guidelines. Principal Responsibilities: Build and maintain solid and credible relationships with the medical community on behalf of MA and CD in academic and community HCP settings as related to MannKind Corporation relevant disease states.
Serve as liaison to investigational sites on behalf of CD. Assist in site identification, evaluation, and training as directed by CD. Provide field insights and observations to the MA and CD organizations on a timely basis.
Work directly with home office staff to ensure that contracted speakers are properly trained and evaluated.
Participate in coordinating and conducting peer-to-peer interactions and medical presentations.
Provide scientific and clinical expertise to organizations important for market access of MannKind Corporation products, including scientific presentations and relevant research projects.
Serve as scientific expert to support internal training activities.
Lead the development of new and update current MCAA resources.
Coordinate MA scientific activities at national and regional medical conferences.
Lead the development of scientific and/or clinical presentations for use by MA and/or CD.
Provide input and actively participate in company publication activities.
Be well versed in the current therapeutic areas, marketed and pipeline assets important to the MA and CD functions.
Coordinate home office consulting meetings with external experts to provide education and insights important to MannKind Corporation business.
Actively participate as a medical reviewer in Review Committee
Provide input and “sign-off” on promotional materials on behalf of MA
Provide overall medical / scientific support through the dissemination of educational, scientific, and clinical information on diseases and its treatment.
Support commercial colleagues as needed from a medical perspective within compliance guidelines
Develop relationships with local thought leaders (physicians, CDEs, pharmacists, and nurses) whose opinions and treatment regimens influence the practice of their colleagues.
Liaise with external investigators for unsolicited requests for investigator-initiated trials (IITs) and coordinate internal IIT committee meetings.
In response to appropriate requests, disseminate to HCPs information on research and medical concepts related to the treatment and management of diseases of interest to the company.
Relay Medical Information requests through appropriate channels.
Duties and responsibilities are not limited to the work listed above and may include other assignments as necessary.
Responsible for observing all Company, Health, Safety and Environmental guidelines and following all applicable policies and procedures.
rew12.ultipro.com/MAN1011/JobBoard/JobDetails.aspx?__ID=*2819E982DB4C9A2E
|
|
|
|
Post by mango on Mar 22, 2019 4:59:16 GMT -5
Post Date 3/21/2019 Title Medical and Clinical Affairs Advisor City Field-based Description MannKind Corporation (NASDAQ:MNKD) focuses on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. MannKind is currently commercializing Afrezza® (insulin human) inhalation powder, the Company's first FDA-approved product and the only inhaled rapid-acting mealtime insulin in the United States, where it is available by prescription from pharmacies nationwide. MannKind is headquartered in Westlake Village, California, and has a state-of-the art manufacturing facility in Danbury, Connecticut. The Company also employs field sales and medical representatives across the U.S. For further information, visit www.mannkindcorp.com. The Medical and Clinical Affairs Advisor (MCAA) is a field-based extension of the Medial Affairs (MA) and Clinical Development (CD) teams responsible for serving as a scientific expert and study liaison to opinion leaders (OLs) and healthcare providers (HCPs) in the academic, medical society, and payer communities as related to MannKind products and related disease states. The MCAA will also have significant responsibility for MA and CD corporate functions as listed below (e.g. PRC, IITs, sales training, etc.). Individuals in this role will be expected to provide in-depth, scientific, clinical and educational information and support to OLs, HCPs, medical societies, and payers, as well as interact with internal clinical, sales and marketing teams to lead relevant scientific corporate activities. The MCAA will have an in-depth understanding of MannKind products and disease states relevant to business needs and will be responsible for providing scientific insights from the field to MA and CD management. In addition, the MCAA will have well-established relationships with national OLs in the diabetes therapeutic area and/or be well-equipped to develop new relationships. Individuals in these positions will provide scientific expertise in a fair balanced, objective, manner in compliance with all applicable policies, regulations, and guidelines. Principal Responsibilities: Build and maintain solid and credible relationships with the medical community on behalf of MA and CD in academic and community HCP settings as related to MannKind Corporation relevant disease states.
Serve as liaison to investigational sites on behalf of CD. Assist in site identification, evaluation, and training as directed by CD. Provide field insights and observations to the MA and CD organizations on a timely basis.
Work directly with home office staff to ensure that contracted speakers are properly trained and evaluated.
Participate in coordinating and conducting peer-to-peer interactions and medical presentations.
Provide scientific and clinical expertise to organizations important for market access of MannKind Corporation products, including scientific presentations and relevant research projects.
Serve as scientific expert to support internal training activities.
Lead the development of new and update current MCAA resources.
Coordinate MA scientific activities at national and regional medical conferences.
Lead the development of scientific and/or clinical presentations for use by MA and/or CD.
Provide input and actively participate in company publication activities.
Be well versed in the current therapeutic areas, marketed and pipeline assets important to the MA and CD functions.
Coordinate home office consulting meetings with external experts to provide education and insights important to MannKind Corporation business.
Actively participate as a medical reviewer in Review Committee
Provide input and “sign-off” on promotional materials on behalf of MA
Provide overall medical / scientific support through the dissemination of educational, scientific, and clinical information on diseases and its treatment.
Support commercial colleagues as needed from a medical perspective within compliance guidelines
Develop relationships with local thought leaders (physicians, CDEs, pharmacists, and nurses) whose opinions and treatment regimens influence the practice of their colleagues.
Liaise with external investigators for unsolicited requests for investigator-initiated trials (IITs) and coordinate internal IIT committee meetings.
In response to appropriate requests, disseminate to HCPs information on research and medical concepts related to the treatment and management of diseases of interest to the company.
Relay Medical Information requests through appropriate channels.
Duties and responsibilities are not limited to the work listed above and may include other assignments as necessary.
Responsible for observing all Company, Health, Safety and Environmental guidelines and following all applicable policies and procedures.
rew12.ultipro.com/MAN1011/JobBoard/JobDetails.aspx?__ID=*2819E982DB4C9A2E
Sounds like a pretty cool job. |
|
|
|
Post by #NoMoreNeedles on Mar 27, 2019 8:10:18 GMT -5
New opening: District Business Manager (Northern California)
|
|
|
|
Post by ltta on May 18, 2019 9:46:21 GMT -5
Three new job listings 5/16/19 for Patient Experience Guide: Westlake Village, Danbury and REMOTE
... Responsibilities clipped...
• Serve as single point of contact for patients throughout the care continuum of enrollment, access, reimbursement, co-pay assistance, education, resource support, addressing any needs throughout.
• Responsible for establishing and maintaining positive working relationships with patients and key stake holders in the patient support process (physicians, office staff, practice managers, nurses, educators, pharmacists, insurers, and others).
• Independently use judgment and decision making in addressing patient needs across their care continuum.
...
|
|
|
|
Post by sportsrancho on May 24, 2019 16:24:02 GMT -5
I have a suggestion ...hire the people that you did not hire that you know were darn qualified, I know five personally, that would not give up, not quit, and who love Afrezza!!
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on May 24, 2019 17:26:28 GMT -5
There are two troubling things. Mike told me when ADA was in San Diego they weren't going because the majority of attendees are not from the US. I can tell you that a large number of the attendees were there from the US including endos, nurse practioners and others that can help move Afrezza forward. Otherwise why did we have to wait for the STAT last year until ADA? The collaborators knew there was a strong US attendance to deliver the study too in a live setting. Secondly the hires they are making clearly reflect that were are not nearing a partnership with a big pharma company that already has regulatory and global regulatory talent in. Why duplicate? Mike did say they would look into other ways to participate in ADA. I guess we will see photos of some presense there. I would suggest that many of the global regulators will have delegates at ADA, so why not impress them ahead of a filing for approval for Afrezza? Troubling.
From the ADA website "World's Largest Diabetes Meeting"
And the CEO said it's not worth having a booth?  |
|
|
|
Post by travis1953 on May 24, 2019 18:07:26 GMT -5
I have a suggestion ...hire the people that you did not hire that you know were darn qualified, I know five personally, that would not give up, not quit, and who love Afrezza!! I'm afraid I'm having trouble deciphering this. So you know 5 people that you feel were very qualified but were not hired? |
|
